CT/NG Testing Market - Global Forecast 2026-2032

The CT/NG Testing Market is undergoing significant transformation as evolving clinical and operational demands reshape diagnostic strategies for chlamydia and gonorrhea. Senior healthcare and laboratory leaders face an increasingly complex environment that demands informed procurement, the adoption of innovative technologies, and robust supply chain resilience to maintain diagnostic quality and strategic agility.

Market Snapshot: CT/NG Testing Market Overview

In 2025, the CT/NG Testing Market reached a value of USD 1.87 billion, with growth to USD 2.02 billion projected by 2026 and an anticipated expansion to USD 3.36 billion by 2032, reflecting a CAGR of 8.65%. These growth figures are underpinned by ongoing investments in advanced molecular diagnostics, expanding adoption within public health frameworks, and rising demand for integrated testing solutions. The market landscape is further influenced by accelerated technology rollouts, evolving reimbursement conditions, and variations in healthcare infrastructure, collectively shaping supplier strategies and procurement models across global regions.

Scope & Segmentation of the CT/NG Testing Market

Technology Architectures: Platforms include nucleic acid amplification tests (NAATs), PCR systems, isothermal amplification, and established culturing or hybridization methods, serving diverse deployment environments from centralized labs to decentralized care settings.
Product Configurations: Offerings encompass consumables and reagents such as kits, probes, primers, control materials, along with instruments ranging from automated analyzers to specialized PCR devices. Supporting software and related services enable workflow automation and compliance.
Test Types: Diagnostic selections span from single-analyte chlamydia or gonorrhea tests to dual assays, which increase patient throughput and bolster diagnostic yield, particularly valuable for high-volume laboratories and point-of-care applications.
End-User Workflows: Academic and research organizations seek assay flexibility, clinics prioritize rapid point-of-care results, diagnostic labs focus on automation and reliability, and hospitals require infection control and uninterrupted supply.
Regional Coverage: Analysis includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, examining distinct approaches to regulatory oversight, procurement logistics, and infrastructure readiness to inform regional adaptation strategies.

Key Takeaways: Strategic Priorities in CT/NG Testing

Integrated diagnostic platforms—combining hardware, reagents, and digital connectivity—streamline laboratory workflows and simplify vendor engagement across expansive healthcare networks.
Adoption of dual and multiplexed assay formats is accelerating in operational settings that benefit from optimized patient encounters and reduced follow-up complexity.
Transitioning from legacy manual assays to advanced molecular and automated systems is driven by ongoing technological innovation and the need for scalable, high-throughput solutions in decentralized care.
Regulatory frameworks and clear reimbursement guidelines strongly influence how rapidly institutions integrate emerging diagnostic technologies, with harmonized certification accelerating adoption.
Supply chain resilience and adaptable procurement arrangements now figure centrally in institutional planning, prompting realignment of vendor contracts and sourcing to address market volatility.
Strategic partnerships between manufacturers, reagent developers, and software firms enable rapid product innovation and provide operational stability throughout evolving market demands.

Tariff Impact on Supply and Procurement Strategies

Recent tariff increases on imported diagnostic components and finished goods in the United States have raised procurement complexities for laboratory and healthcare organizations. Many institutions have altered supply strategies through contract renegotiation, adjusted inventory management, or participation in group purchasing to control cost pressures. Manufacturers and distributors have mitigated tariff impacts by increasing regional sourcing, adopting nearshoring models, and automating production processes. These measures influence test ordering behaviors by prioritizing high-yield diagnostic protocols and adaptive contracts, especially important in environments where budgets are under scrutiny. Clearer policy communication and temporary measures for critical medical supplies have supported supply continuity, but have also highlighted the enduring need for robust supply chain management and cost controls.

Technology and Regional Dynamics

Technological momentum and local infrastructure readiness continue to segment the global CT/NG Testing Market. The Americas emphasize scalability and ensure consistent diagnostic services across large health systems, while Europe and Middle East & Africa adapt to more fragmented procurement structures and a need for modular, resilient laboratory platforms. In Asia-Pacific, a mix of centralized laboratory solutions and decentralized, rapid testing meet expanding population health requirements. Public health priorities are directly shaping the adoption rates of dual and multiplexed assays, and service models are being tailored to fit divergent regulatory demands, reimbursement policies, and operational challenges unique to each market.

Methodology & Data Sources

Market assessment is based on structured interviews with laboratory executives, procurement professionals, clinical leaders, and regulatory authorities. These insights are synthesized with findings from vendor briefings, protocol analyses, peer-reviewed research, regulatory documents, and company statements. Expert validation ensures that the analysis captures key trends and operational realities.

Why This Report Matters

Delivers actionable intelligence to guide senior leaders in refining procurement strategies, capital investment, and diagnostic policy in a rapidly evolving market.
Highlights key advances in testing technology, supply arrangements, and service models that enhance operational efficiency and clinical decision-making across healthcare settings.
Supports anticipatory planning so organizations can address shifting regulatory, operational, and supply chain risks effectively.

Conclusion

Success in the CT/NG Testing Market depends on aligning procurement practices, technology adoption, and regulatory readiness to maintain diagnostic excellence. A resilient, strategic approach ensures ongoing clinical value and operational efficiency as the market evolves.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. CT/NG Testing Market, by Technology

8.1. Culturing Methods
8.2. Hybridization Assays
8.3. Immunoassays
8.4. Nucleic Acid Amplification Tests
8.4.1. Isothermal Amplification
8.4.1.1. Loop Mediated Isothermal Amplification
8.4.1.2. Transcription Mediated Amplification
8.4.2. Polymerase Chain Reaction
8.4.2.1. Nested Polymerase Chain Reaction
8.4.2.2. Real Time Polymerase Chain Reaction

9. CT/NG Testing Market, by Product Type

9.1. Consumables And Reagents
9.1.1. Control Materials
9.1.2. Kits
9.1.3. Probes And Primers
9.2. Instruments
9.2.1. Automated Systems
9.2.2. Hybridization Analyzers
9.2.3. Polymerase Chain Reaction Instruments
9.3. Software And Services

10. CT/NG Testing Market, by Test Type

10.1. Chlamydia Tests
10.2. Dual Tests
10.3. Gonorrhea Tests

11. CT/NG Testing Market, by End User

11.1. Academic And Research Institutes
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Hospitals

12. CT/NG Testing Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. CT/NG Testing Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. CT/NG Testing Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States CT/NG Testing Market
16. China CT/NG Testing Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Becton, Dickinson and Company
17.7. Binx Health, Inc.
17.8. Bio-Rad Laboratories, Inc.
17.9. Bioneer Corporation
17.10. Danaher Corporation
17.11. ELITech Group SAS
17.12. F. Hoffmann-La Roche Ltd.
17.13. Geneproof A.S.
17.14. Genetic Signatures Ltd.
17.15. Goffin Molecular Technologies B.V.
17.16. Hologic, Inc.
17.17. Meridian Bioscience Inc.
17.18. Microbiologics, Inc.
17.19. Molbio Diagnostics Pvt. Ltd.
17.20. Operon S.A.
17.21. PerkinElmer Inc.
17.22. QIAGEN N.V.
17.23. Sansure Biotech Inc.
17.24. Seegene, Inc.
17.25. Siemens Healthineers AG
17.26. Thermo Fisher Scientific Inc.
17.27. Tianlong Technology Co., Ltd.
17.28. Vircell S.L.
17.29. Visby Medical, Inc.

List of Figures

FIGURE 1. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CT/NG TESTING MARKET SIZE, BY CULTURING METHODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY CULTURING METHODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY CULTURING METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CT/NG TESTING MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CT/NG TESTING MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CT/NG TESTING MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CT/NG TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CT/NG TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CT/NG TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CT/NG TESTING MARKET SIZE, BY NESTED POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CT/NG TESTING MARKET SIZE, BY NESTED POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CT/NG TESTING MARKET SIZE, BY NESTED POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CT/NG TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CT/NG TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CT/NG TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CT/NG TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CT/NG TESTING MARKET SIZE, BY CONTROL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CT/NG TESTING MARKET SIZE, BY CONTROL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CT/NG TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CT/NG TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CT/NG TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CT/NG TESTING MARKET SIZE, BY PROBES AND PRIMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CT/NG TESTING MARKET SIZE, BY PROBES AND PRIMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CT/NG TESTING MARKET SIZE, BY PROBES AND PRIMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CT/NG TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CT/NG TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CT/NG TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CT/NG TESTING MARKET SIZE, BY HYBRIDIZATION ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CT/NG TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CT/NG TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CT/NG TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CT/NG TESTING MARKET SIZE, BY CHLAMYDIA TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CT/NG TESTING MARKET SIZE, BY CHLAMYDIA TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CT/NG TESTING MARKET SIZE, BY CHLAMYDIA TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CT/NG TESTING MARKET SIZE, BY DUAL TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CT/NG TESTING MARKET SIZE, BY DUAL TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CT/NG TESTING MARKET SIZE, BY DUAL TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CT/NG TESTING MARKET SIZE, BY GONORRHEA TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CT/NG TESTING MARKET SIZE, BY GONORRHEA TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CT/NG TESTING MARKET SIZE, BY GONORRHEA TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CT/NG TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CT/NG TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CT/NG TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CT/NG TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CT/NG TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CT/NG TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CT/NG TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPE CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 153. AFRICA CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 154. AFRICA CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 155. AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. AFRICA CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 157. AFRICA CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. AFRICA CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL CT/NG TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 174. ASEAN CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 175. ASEAN CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 176. ASEAN CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASEAN CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASEAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. GCC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GCC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. GCC CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 184. GCC CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 185. GCC CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 186. GCC CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. GCC CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 188. GCC CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 189. GCC CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 190. GCC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. BRICS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. BRICS CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 204. BRICS CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 205. BRICS CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 206. BRICS CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. BRICS CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 208. BRICS CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 209. BRICS CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 210. BRICS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. G7 CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. G7 CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. G7 CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 214. G7 CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 215. G7 CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 216. G7 CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 217. G7 CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 218. G7 CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 219. G7 CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. NATO CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NATO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. NATO CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 224. NATO CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 225. NATO CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 226. NATO CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. NATO CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 228. NATO CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 229. NATO CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 230. NATO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA CT/NG TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. CHINA CT/NG TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TESTS, 2018-2032 (USD MILLION)
TABLE 245. CHINA CT/NG TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
TABLE 246. CHINA CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 247. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. CHINA CT/NG TESTING MARKET SIZE, BY CONSUMABLES AND REAGENTS, 2018-2032 (USD MILLION)
TABLE 249. CHINA CT/NG TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 250. CHINA CT/NG TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 251. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this CT/NG Testing market report include:

Abbott Laboratories
Becton, Dickinson and Company
Binx Health, Inc.
Bio-Rad Laboratories, Inc.
Bioneer Corporation
Danaher Corporation
ELITech Group SAS
F. Hoffmann-La Roche Ltd.
Geneproof A.S.
Genetic Signatures Ltd.
Goffin Molecular Technologies B.V.
Hologic, Inc.
Meridian Bioscience Inc.
Microbiologics, Inc.
Molbio Diagnostics Pvt. Ltd.
Operon S.A.
PerkinElmer Inc.
QIAGEN N.V.
Sansure Biotech Inc.
Seegene, Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Tianlong Technology Co., Ltd.
Vircell S.L.
Visby Medical, Inc.

Table Information

Report Attribute	Details
No. of Pages	194
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.02 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.36 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: CT/NG Testing Market Overview

Scope & Segmentation of the CT/NG Testing Market

Key Takeaways: Strategic Priorities in CT/NG Testing

Tariff Impact on Supply and Procurement Strategies

Technology and Regional Dynamics

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

CT-NG Molecular Test Market Report: Trends, Forecast and Competitive Analysis to 2031

CT-NG Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

Spiral CT Scanner Global Market Insights 2026, Analysis and Forecast to 2031

Metal For CT X-ray Tube Market - Global Forecast 2025-2030

Positron Emission Tomography Market Report by Product Type, Detector Type, Application, End-User Countries and Company Analysis 2025-2033